HUPO: Comparison of Proteograph Product Suite to Traditional Peptide Fractionation

October 27th, 2020 by

Mark Flory, Ph.D. from Oregon Health Sciences University, Knight Cancer Institute, CEDAR shares a comparison of traditional deep proteomics by protein fractionation with the Seer Proteograph Product Suite Read More

The Challenge in Proteomics Today: Why We Need Unbiased, Deep, Rapid and Scalable Proteomics

October 20th, 2020 by

John Blume, Ph.D., discusses the current challenges in proteomics, the technological barriers we need to remove and how Seer’s Proteograph Product Suite is uniquely positioned to solve these challenges Read More

Nature Communications: Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona

July 22nd, 2020 by

This Nature Communications paper demonstrates that Protegraph technology is unmatched in its combination of depth, breadth, and speed—creating the necessary scale for proteomics profiling studies that lead to unprecedented discovery. Read More

ASMS: Proteograph platform significantly improves coverage, throughput, and scalability versus existing methods

June 1st, 2020 by

This ASMS 2020 poster shows how the Proteograph platform is the first unbiased platform for large-scale proteome profiling studies quantifying thousands of proteins across large numbers of samples. Read More

AACR: Plasma protein-protein interactome (PPI) maps for non-small cell lung cancer (NSCLC) using the Proteograph Product Suite

April 22nd, 2020 by

This AACR 2020 poster demonstrates how the Proteograph platform can be used to identify PPI clusters that are differentiated between NSCLC and control individuals. Read More

AACR: Analytical validation of the Proteograph platform for rapid and deep proteomic profiling

April 20th, 2020 by

This AACR 2020 poster demonstrates how Seer's proprietary nanoparticle technology can be optimized for unbiased, deep plasma proteome profiling. Read More

AACR: Scalable plasma proteomics in early-stage non-small cell lung cancer

April 10th, 2020 by

This AACR 2020 poster demonstrates the utility of the Proteograph platform to deeply profile plasma proteins as novel biomarkers in healthy vs. early NSCLC Read More

US HUPO: Deep, Unbiased Plasma Protein Profiling and Protein-Protein Interaction vs Fractionation

March 12th, 2020 by

Compared to typical fractionation, the Proteograph platform has superior coverage, depth, precision, and accuracy in unbiased proteomic profiling. Read More